EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Consistency of Serial Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay Results in the Parkinson's Precision Medicine Initiative

David G. Coughlin, Caroline Gochanour, Jie Yin, Luis Concha‐Marambio, Carly Farris, Yihua Ma, David‐Erick Lafontant, Edwin Jabbari, Tanya Simuni, Ken Marek, Thomas F. Tropea

Movement Disorders · 2026-10-12

DOI: 10.1002/mds.70509 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Studies reporting α‐synuclein seed amplification assay (aSyn‐SAA) results are often cross‐sectional. Objectives In this study, we investigated the intraindividual consistency of aSyn‐SAA results (Amprion) over time from participants in the Parkinson's Precision Medicine Initiative (PPMI). Methods A total of 1238 participants had >1 cerebrospinal fluid (CSF) aSyn‐SAA result for analysis (Parkinson's disease [PD] = 633, prodromal = 563, healthy control [HC] = 42), collected over a median (minimum, maximum) of 2.0 (0.4, 11.4) years. Emphasis was placed on evaluating consistency in aSyn‐SAA‐PD participants, aSyn‐SAA + HC participants, and conversion rates from aSyn‐SAA negative to positive results prodromal participants. Results Of aSyn‐SAA + PD participants, 96% (474/493, 95% confidence interval [CI]: 94%–98%) remained positive in subsequent samples, and 92% (116/126, 95% CI: 86%–96%) of aSyn‐SAA‐PD participants remained negative. Ninety‐nine percent (303/307, 95% CI: 97%–99%) of aSyn‐SAA + prodromal participants remained positive, and 95% (234/247, 95% CI: 91%–97%) of aSyn‐SAA‐prodromal participants remained negative. Eighty‐nine percent (16/18, 95% CI: 67%–97%) of aSyn‐SAA + HC participants remained positive, and 87% (20/23, 95% CI: 68%–95%) of aSyn‐SAA‐HC participants remained negative. Conclusions aSyn‐SAA testing is highly consistent over time, even in less expected scenarios. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →